Fujigraf 1 Capsule contains Tacrolimus 1mg, an immunosuppressant medication primarily used to prevent organ rejection in patients who have undergone kidney, liver, or heart transplantation. Tacrolimus works by inhibiting calcineurin, a protein phosphatase involved in activating T-cells of the immune system, thereby reducing the body's immune response and minimizing the risk of transplant rejection. Fujigraf is typically prescribed as part of a combination therapy alongside corticosteroids or other immunosuppressive agents to enhance efficacy and improve patient outcomes. It is essential to take Fujigraf exactly as directed by a healthcare professional, as improper use can increase the risk of infections, malignancies, or other adverse effects. Common side effects may include headache, tremors, gastrointestinal disturbances, increased blood sugar levels, and kidney function alterations. Regular monitoring of blood levels, kidney function, and blood pressure is crucial during treatment to ensure safety and effectiveness. Patients should avoid grapefruit and grapefruit juice while taking Fujigraf, as these can interfere with the metabolism of Tacrolimus and lead to increased drug levels. Fujigraf should not be used in patients with known hypersensitivity to Tacrolimus or its components. Always consult a healthcare provider before starting or stopping this medication.